KfW

Type

Bank

Status

Active

Location

Frankfurt, Germany

Total investments

178

Average round size

25M

Portfolio companies

135

Rounds per year

2.34

Lead investments

14

Follow on index

0.24

Exits

39

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyE-CommerceInternetSoftwareInformation TechnologyHealth CareManufacturingMedical DeviceMedicalTherapeutics

Summary

KfW is the famous Corporate Investor, which was founded in 1948. The main department of described Corporate Investor is located in the Deutsch. The fund was located in Europe if to be more exact in Germany.

The important activity for fund was in 2011. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in 7-12 deals every year. The average startup value when the investment from KfW is 1-5 millions dollars. Comparing to the other companies, this KfW performs on 9 percentage points less the average number of lead investments. The real fund results show that this Corporate Investor is 10 percentage points less often commits exit comparing to other companies. The increased amount of exits for fund were in 2015.

Besides them, we counted 5 critical employees of this fund in our database.

Among the most successful fund investment fields, there are Pharmaceutical, Health Care. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Zalando, Shelter Afrique, simplesurance.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the KfW, startups are often financed by Bayern Kapital GmbH, Peppermint Venture Partners, Unternehmertum Venture Capital Partners. The meaningful sponsors for the fund in investment in the same round are MIG AG, NRW.BANK, Seed Fond Aachen. In the next rounds fund is usually obtained by Bayern Kapital GmbH, High-Tech Gru00fcnderfonds, NRW.BANK.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
178
Lead investments
14
Exits
39
Rounds per year
2.34
Follow on index
0.24
Investments by industry
  • Biotechnology (51)
  • Health Care (34)
  • Software (33)
  • Medical (30)
  • Medical Device (18)
  • Show 170 more
Investments by region
  • Germany (165)
  • South Africa (2)
  • India (2)
  • Kenya (2)
  • Namibia (1)
  • Show 5 more
Peak activity year
2011
Number of Unicorns
4
Number of Decacorns
4
Number of Minotaurs
4

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
15
Avg. valuation at time of investment
67M
Group Appearance index
0.88
Avg. company exit year
10
Avg. multiplicator
0.08
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
CryoTherapeutics 02 Apr 2024 Therapeutic Devices, Biotechnology, Health Care, Medical, Therapeutics, Clinical Trials Early Stage Venture 11M Brandenburg, Potsdam, Germany
SuppreMol 15 Jul 2008 Biotechnology, Health Care, Medical Device Early Stage Venture 18M Germany, Bavaria, Germany

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.